PI
IONS icon

Placemark Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Placemark Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.93M Buy
47,423
+5,960
+14% +$294K 0.05% 446
2014
Q3 		$1.61M Buy
41,463
+5,902
+17% +$209K 0.03% 643
2014
Q2 		$1.23M Sell
35,561
-4,614
-11% -$145K 0.02% 779
2014
Q1 		$1.74M Buy
40,175
+14,714
+58% +$713K 0.03% 594
2013
Q4 		$1.01M Buy
25,461
+1,896
+8% +$67.6K 0.02% 843
2013
Q3 		$886K Buy
23,565
+4,780
+25% +$143K 0.02% 865
2013
Q2 		$505K Buy
+18,785
New +$399K 0.01% 1030

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Placemark Investments's IONS Position: Q4 2014 in Review

Placemark Investments increased its Ionis Pharmaceuticals (IONS) stake by 14% in Q4 2014, buying an estimated $294K and bringing the position to 47,423 shares worth $2.93M. The position accounts for 0.05% of the portfolio, ranked #446.

Placemark Investments first reported a position in IONS in Q2 2013 and has held it in 7 quarters since. 285 funds tracked by Wall St. Rank hold IONS as of Q4 2014.

  • Placemark Investments held 47,423 shares of Ionis Pharmaceuticals worth $2.93M as of Q4 2014.
  • Placemark Investments bought 5,960 Ionis Pharmaceuticals shares in Q4 2014, an estimated $294K.
  • Ionis Pharmaceuticals made up 0.05% of Placemark Investments's portfolio in Q4 2014, its #446 holding.
  • Placemark Investments first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 285 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.